Table 1-A.
Clinicopathological findings of the colorectal lesions.
| Cohort 1 (microarray) (%) | Cohort 2 (validation test) (%) | |||
|---|---|---|---|---|
| Sex | ||||
| Male | 29 | (69) | 19 | (51.4) |
| Female | 13 | (31) | 18 | (48.6) |
| Age, median (range) | 67 | (43-81) | 67 | (46-85) |
| Location | ||||
| C/A/T/D/S/R | 2/8/6/3/11/12 | 4/10/1/1/8/13 | ||
| Histological type | ||||
| Conventional adenoma | 15 | (35.7) | 15 | (40.5) |
| Intramucosal cancer | 8 | (19) | 8 | (21.6) |
| Colorectal cancer with an MSS phenotype | 19 | (45.2) | 14 | (37.8) |
| MDA | 18 | (94.7) | 13 | (92.9) |
| MUC | 1 | (5.3) | 1 | (7.1) |
| Stage | ||||
| I | 3 | (15.8) | 4 | (28.6) |
| II | 6 | (31.6) | 5 | (35.7) |
| III | 7 | (36.8) | 4 | (28.6) |
| IV | 3 | (15.8) | 1 | (7.1) |
C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; R, rectum; MSS, microsatellite stable; MDA, moderately differentiated adenocarcinoma; MUC, mucinous carcinoma.